Clinical trials
Completed Phase 1 Bone Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Alberta Health services | 1 |
| Boston Scientific Corporation | 1 |
| Celgene | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Gradalis, Inc. | 1 |
| InSightec | 1 |
| Italian Sarcoma Group | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Neoplasms | 17 |
| Sarcoma | 9 |
| Breast Neoplasms | 5 |
| Lung Neoplasms | 3 |
| Melanoma | 3 |
| Neoplasms | 3 |
| Neuroectodermal Tumors, Primitive, Peripheral | 3 |
| Osteosarcoma | 3 |
| Prostatic Neoplasms | 3 |
| Testicular Neoplasms | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.